Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Hold
18,643
0.12% 82
2026
Q1
$1.75M Hold
18,643
0.12% 86
2025
Q4
$1.84M Sell
18,643
-379
-2% -$36.7K 0.11% 78
2025
Q3
$1.61M Hold
19,022
0.1% 80
2025
Q2
$1.3M Hold
19,022
0.08% 88
2025
Q1
$1.15M Hold
19,022
0.09% 96
2024
Q4
$1.31M Sell
19,022
-500
-3% -$35.6K 0.09% 98
2024
Q3
$1.29M Hold
19,522
0.09% 93
2024
Q2
$1.18M Hold
19,522
0.08% 96
2024
Q1
$1.11M Buy
+19,522
New +$1.17M 0.08% 99
2023
Q4
Sell
-25,685
Closed -$1.48M 136
2023
Q3
$1.48M Sell
25,685
-1,966
-7% -$124K 0.12% 87
2023
Q2
$1.72M Buy
+27,651
New +$1.85M 0.14% 83

Other funds holding INCY

Oak Associates's INCY Position: Q2 2026 in Review

Oak Associates held its Incyte (INCY) position steady in Q2 2026 at 18,643 shares worth $2.11M. The position accounts for 0.12% of the portfolio, ranked #82.

Oak Associates first reported a position in INCY in Q2 2023 and has held it in 12 quarters since. 858 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Oak Associates held 18,643 shares of Incyte worth $2.11M as of Q2 2026.
  • Oak Associates left its Incyte share count unchanged in Q2 2026.
  • Incyte made up 0.12% of Oak Associates's portfolio in Q2 2026, its #82 holding.
  • Oak Associates first reported a position in Incyte in Q2 2023 and has held it in 12 quarters since.
  • 858 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Oak Associates's 13F filing for Q2 2026, filed 14 Aug 2026.